Patient Square Capital L.P. 13F annual report
Patient Square Capital L.P. is an investment fund managing more than $215 billion ran by Adam Fliss. There are currently 2 companies in Mr. Fliss’s portfolio. The largest investments include Roivant Sciences Ltd and Liquidia Corp, together worth $215 billion.
$215 billion Assets Under Management (AUM)
As of 6th August 2024, Patient Square Capital L.P.’s top holding is 12,228,465 shares of Roivant Sciences Ltd currently worth over $129 billion and making up 60.0% of the portfolio value.
In addition, the fund holds 7,182,532 shares of Liquidia Corp worth $86.2 billion, whose value fell 18.6% in the past six months.
Currently, Patient Square Capital L.P.'s portfolio is worth at least $215 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Patient Square Capital L.P.
The Patient Square Capital L.P. office and employees reside in Menlo Park, California. According to the last 13-F report filed with the SEC, Adam Fliss serves as the Founding Partner and General Counsel at Patient Square Capital L.P..
One of the smallest hedge funds
The two most similar investment funds to Patient Square Capital L.P. are Red Spruce Capital and Canopy Partners. They manage $215 billion and $215 billion respectively.
Adam Fliss investment strategy
Patient Square Capital L.P.’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 40.0% of
the total portfolio value.
The fund focuses on investments in the United States as
50.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $309 million.
The complete list of Patient Square Capital L.P. trades based on 13F SEC filings
These positions were updated on August 13th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Roivant Sciences Ltd |
No change
12,228,465
|
$129,254,875,000 | 59.99% |
| Liquidia Corp |
No change
7,182,532
|
$86,190,384,000 | 40.01% |
| No transactions found | |||
| Showing first 500 out of 2 holdings | |||
Hedge funds similar to Patient Square Capital L.P.
- Pcj Investment Counsel
- Simplifi
- Montis
- Palumbo Wealth Management
- Dalal Street
- Deseret Mutual Benefit Administrators
- Axis Capital Holdings Ltd
- Red Spruce Capital
- Canopy Partners
- Codex Capital Asset Management L.L.C
- Enervest
- Royal Harbor Partners
- Solitude Services
- Scarborough Advisors